Canopus BioPharma Incorporated (CBIA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2014 | 2013 |
|---|---|---|---|---|
| Total Assets | 4215.00 | 900.00 | 1.56 Million | 1.75 Million |
| Total Current Assets | 4215.00 | 900.00 | 28.64 Thousand | 100.00 |
| Cash And Short Term Investments | 4215.00 | - | 28.64 Thousand | 100.00 |
| Cash and Cash Equivalents | 4215.00 | - | 28.64 Thousand | 100.00 |
| Short Term Investments | - | - | - | - |
| Net Receivables | - | 900.00 | - | - |
| Inventory | - | - | - | - |
| Other Current Assets | - | - | - | - |
| Total Non-Current Assets | - | - | 1.53 Million | 1.75 Million |
| Net PPE | - | - | - | - |
| Good Will And Intangible Assets | - | - | 960.68 Thousand | 1.32 Million |
| Good Will | - | - | - | - |
| Intangible Assets | - | - | 960.68 Thousand | 1.32 Million |
| Long-Term Investments | - | - | - | - |
| Tax Assets | - | - | - | - |
| Other Non Current Assets | - | - | 573.73 Thousand | 428.86 Thousand |
| Other Assets | - | - | - | - |
| Total Liabilities | 17.49 Thousand | - | 2.1 Million | 4.38 Million |
| Total Current Liabilities | 17.49 Thousand | - | 2.1 Million | 4.38 Million |
| Account Payables | 7225.00 | - | - | - |
| Tax Payables | - | - | - | - |
| Short Term Debt | 10.27 Thousand | - | 1.85 Million | 4.05 Million |
| Deferred Revenue | - | - | - | - |
| Other Current Liabilities | - | - | 255 Thousand | 329.23 Thousand |
| Total Non Current Liabilities | - | - | - | - |
| Long-Term Debt | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - |
| Other Liabilities | - | - | - | - |
| Total Equity | -13.28 Thousand | 900.00 | -542.69 Thousand | -2.63 Million |
| Stock Holders Equity | -13.28 Thousand | 900.00 | -542.69 Thousand | -2.63 Million |
| Common Stock | 1221.00 | 1004.00 | 306.48 Thousand | 273.97 Thousand |
| Retained Earnings | -766.46 Thousand | -1755.00 | -10.19 Million | -9.66 Million |
| Accumulated other comprehensive income | 753.17 Thousand | 2645.00 | 7.96 Million | 7.55 Million |
| Common Stock Equity | -13.28 Thousand | 900.00 | -542.69 Thousand | -2.63 Million |
| Capital Lease Obligation | - | - | - | - |
| Total Investments | - | - | - | - |
| Total Debt | 10.27 Thousand | - | 1.85 Million | 4.05 Million |
| Net Debt | 6057.00 | - | 1.82 Million | 4.05 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | - | 6153.00 | 3175.00 | 4215.00 | 4215.00 | 7806.00 |
| Total Current Assets | - | 6153.00 | 3175.00 | 4215.00 | 4215.00 | 7806.00 |
| Cash And Short Term Investments | - | 6153.00 | 3175.00 | 4215.00 | 4215.00 | 7806.00 |
| Cash and Cash Equivalents | - | 6153.00 | 3175.00 | 4215.00 | 4215.00 | 7806.00 |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | - | 191.1 Thousand | 17.62 Thousand | 17.49 Thousand | 17.49 Thousand | 17.37 Thousand |
| Total Current Liabilities | - | 191.1 Thousand | 17.62 Thousand | 17.49 Thousand | 17.49 Thousand | 17.37 Thousand |
| Account Payables | - | 7225.00 | 7225.00 | 7225.00 | 7225.00 | 7225.00 |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | 183.88 Thousand | 10.39 Thousand | 10.27 Thousand | 10.27 Thousand | 10.14 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - | - |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | - | -184.95 Thousand | -14.44 Thousand | -13.28 Thousand | -13.28 Thousand | -9564.00 |
| Stock Holders Equity | - | -184.95 Thousand | -14.44 Thousand | -13.28 Thousand | -13.28 Thousand | -9564.00 |
| Common Stock | - | 1401.00 | 1392.00 | 1221.00 | 1221.00 | 1221.00 |
| Retained Earnings | - | -1.75 Million | -1.54 Million | -766.46 Thousand | -766.46 Thousand | -762.74 Thousand |
| Accumulated other comprehensive income | - | -1401.00 | 1.56 Million | 1.53 Million | 753.17 Thousand | 753.17 Thousand |
| Common Stock Equity | - | -184.95 Thousand | -14.44 Thousand | -13.28 Thousand | -13.28 Thousand | -9564.00 |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | 183.88 Thousand | 10.39 Thousand | 10.27 Thousand | 10.27 Thousand | 10.14 Thousand |
| Net Debt | - | 177.73 Thousand | 7221.00 | 6057.00 | 6057.00 | 2339.00 |
DBGI
SLNG
2515
FRX
ADVLIFE
180640